Gastric or Esophagogastric Junction Adenocarcinoma Clinical Trials in Shanghai, Huangpu District
2 recruitingShanghai, Huangpu District, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ Adenocarcinoma
Gastric or Esophagogastric Junction Adenocarcinoma
Ruijin Hospital88 enrolled1 locationNCT07569068
Recruiting
Phase 2
LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study
Peritoneal Metastases From Gastric CancerGastric Cancer Stage IVGastric or Esophagogastric Junction Adenocarcinoma
Ruijin Hospital74 enrolled1 locationNCT07556640